关键词：雾化器；医疗器械；药物输送装置；转换药物溶液
摘 要：The Global Nebulizers market forms a significant part of the Global Drug Delivery Devices market. The Global Nebulizers market is growing at a steady pace and is expected to grow at a CAGR of 6.17 percent during 2013-2018. In terms of geography, the Americas dominated the market in 2013, followed by the EMEA and APAC regions. The US, which has the world's highest per capita healthcare expenditure, was the leading revenue contributor to the Nebulizers market in the Americas in the same year.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Technology

07.1 Global Jet Nebulizers Market

07.1.1 Market Size and Forecast

07.2 Global Ultrasonic Nebulizers Market

07.2.1 Market Size and Forecast

07.3 Global In-line Nebulizers Market

07.3.1 Market Size and Forecast

08. Market Segmentation by Product

08.1 Global Nebulizer Devices Market

08.1.1 Market Size and Forecast

08.2 Global Nebulizer Accessories Market

08.2.1 Market Size and Forecast

09. Geographical Segmentation

09.1 Nebulizers Market in the Americas

09.1.1 Market Size and Forecast

09.2 Nebulizers Market in the EMEA Region

09.2.1 Market Size and Forecast

09.3 Nebulizers Market in the APAC Region

09.3.1 Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

17.1 Competitive Scenario

17.1.1 Key News

17.1.2 Mergers and Acquisitions

17.2 Market Share Analysis 2013

17.3 Other Prominent Vendors

17.4 Competitive Analysis of the Global In-line

Nebulizers Market

17.4.1 Product Portfolio of Vendors in the Global In-line

Nebulizers Market

18. Key Vendor Analysis

18.1 Aerogen Ltd.

18.1.1 Key Facts

18.1.2 Business Overview

18.1.3 Partnerships and Agreements

18.1.4 Business Strategy

18.1.5 Key Information

18.1.6 Key Financial Information

18.1.7 SWOT Analysis

18.1.8 Strengths

18.1.9 Weakness

18.1.10 Opportunities

18.1.11 Threats

18.2 GF Health Products Inc.

18.2.1 Key Facts

18.2.2 Business Overview

18.2.3 Business Segmentation

18.2.4 Key Information

18.2.5 Business Strategy

18.2.6 SWOT Analysis

18.2.7 Strengths

18.2.8 Weakness

18.2.9 Opportunities

18.2.10 Threats

18.3 OMRON Corp.

18.3.1 Key Facts

18.3.2 Business Description

18.3.3 Business Segmentation

18.3.4 Business Strategy

18.3.5 Revenue Segmentation by Business

18.3.6 Revenue Comparison - 2012 and 2013

18.3.7 Sales by Geographical Segmentation

18.3.8 Key Information

18.3.9 SWOT Analysis

18.3.10 Strengths

18.3.11 Weaknesses

18.3.12 Opportunities

18.3.13 Threats

18.4 PARI Medical Holding GmbH

18.4.1 Key Facts

18.4.2 Business Overview

18.4.3 Key Subsidiaries

18.4.4 Key Information

18.4.5 Business Strategy

18.4.6 SWOT Analysis

18.4.7 Strengths

18.4.8 Weakness

18.4.9 Opportunities

18.4.10 Threats

18.5 Philips Healthcare

18.5.1 Key Facts

18.5.2 Business Description

18.5.3 Business Segmentation

18.5.4 Business Strategy

18.5.5 Revenue Segmentation by Business

18.5.6 Sales by Geographical Segmentation

18.5.7 Key Information

18.5.8 SWOT Analysis

18.5.9 Strengths

18.5.10 Weaknesses

18.5.11 Opportunities

18.5.12 Threats

19. Other Reports in this Series